BioCatalystWatch
APVOWorkspace / APVO / OverviewCompany library
Aptevo Therapeutics Inc. logo

Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc. (APVO)

Website

Price
Market cap
Next catalystDec 12-15, 2026Mipletamig · Data readoutCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

APVO451

Nectin-4 × CD40 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

RPTs – Initial Target Nectin-4 / Ac-225

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

APVO451

Nectin-4 × CD40 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

RPTs – Initial Target Nectin-4 / Ac-225

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

ALG-APV-527

5T4 × 4-1BB (CD137)

PreINDP1P2P3FilingApproved
Mipletamig

CD123 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

APVO442

PSMA × CD3

PreINDP1P2P3FilingApproved
APVO452

PSMA × CD40 × CD3

PreINDP1P2P3FilingApproved
APVO711

PD-L1 × CD40

PreINDP1P2P3FilingApproved
APVO455

Nectin-4 × CD3

PreINDP1P2P3FilingApproved
APVO603

4-1BB (CD137) × OX40 (CD134)

PreINDP1P2P3FilingApproved

Partner / License out

CD20

Approved

PreINDP1P2P3FilingApproved

CD20

Approved

PreINDP1P2P3FilingApproved

CD20

Approved

PreINDP1P2P3FilingApproved

CD20

Approved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

APVO PR & News

PR & News

APVO SEC archive